BridgeMD
New treatment option for End Stage Renal Disease
Official title Blood Flow Conditions and Sounds in AVFs
ClinicalTrials.gov ID: NCT06411353
What this study is testing
- What it's testing
- This is a prospective non-pharmacological interventional study aimed at investigating the relationship between the blood flow condition and the arteriovenous fistula (AVF) sound, with the ultimate aim of predicting the AVF clinical, in patients with end-stage renal disease (ESRD) who require the creation of a vascular access for extracorporeal circulation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Provision of informed consent prior to any study specific procedures.
- Female and/or male aged between 18 and 90 years.
- Patients in HD treatment who need a new VA or patients who entered the pre-dialysis program because of ESRD. In all cases, the first-choice treatment...
You likely can't join if
- Contraindications for the creation of an autogenous AVF.
- Presence of a previously failed AVF in the same arm selected for surgery.
- Patients with contraindications to MRI including: pregnancy, claustrophobia, cardiac pacemakers or other MRI-incompatible prostheses.
- Patients already on HD treatment through a catheter or a graft.
- Patients undergoing peritoneal dialysis.
- Patients with a life expectancy of less than 2 years.
The study team makes the final eligibility decision.
Where it's taking place
- Bergamo, Bergamo, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergamo, Bergamo, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.